Abstract
We have analyzed matched serum and breast cyst fluid samples for total PSA from 148 patients with fibrocystic breast disease. We have also determined the molecular forms of PSA (free PSA and PSA bound to α1‐antichymotrypsin) in 78 breast cyst fluid samples. We found that total PSA can be detected in all cyst fluids and in about 75% of female sera. The median total PSA concentration in breast cyst fluid (bcf) is about 30 times higher than the median in the corresponding sera. Breast cyst fluid and serum PSA are not correlated with each other. Total serum PSA is inversely associated with patient age but the inverse association between bcf PSA and age is weak. Lower total PSA in bcf was seen in women who breast feed, and higher bcf PSA is associated with multiple cysts. Type I cysts (with a high K+/Na+ ratio) tend to have higher total PSA than Type II cysts. All but three of the fractionated cyst fluids (75/78; 96%) had free PSA as the predominant molecular form. The most consistent finding of our study was the positive association between the cyst fluid K+/Na+ ratio and the free to bound PSA ratio. This association was confirmed by Spearman correlation as well as by Wilcoxon and chi‐square analysis. Secretory/apocrine cysts (Type I) tend to have more total PSA and proportionally more free PSA than transudative/flattened cysts (Type II). J. Clin. Lab. Anal. 13:75–81, 1999. © 1999 Wiley‐Liss, Inc.
Keywords: prostate specific antigen, breast cyst fluid, fibrocystic breast diseases, molecular forms of PSA, free/bound PSA ratio, electrolyte ratio
REFERENCES
- 1. Yu H, Diamandis EP, Sutherland DJA. Immunoreactive prostate‐specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clin Biochem 1994;27:75–79. Medline [DOI] [PubMed] [Google Scholar]
- 2. Levesque M, Yu H, D’Costa M, Diamandis EP. Prostate‐specific antigen expression by various tumors. J Clin Lab Anal 1995;9:123–128. Medline [DOI] [PubMed] [Google Scholar]
- 3. Ferguson RA, Yu H, Kalyvas M, Zammit S, Diamandis E. Ultrasensitive detection of prostate‐specific antigen by a time‐resolved immunofluorometric assay and the Immulite® immunochemiluminescent third‐generation assay: potential applications in prostate and breast cancers. Clin Chem 1996;42:675–684. Medline [PubMed] [Google Scholar]
- 4. Yu H, Giai M, Diamandis EP, et al. Prostate‐specific antigen is a new favorable prognostic indicator for women with breast cancer. Cancer Res 1995;55:2104–2110. Medline [PubMed] [Google Scholar]
- 5. Yu H, Diamandis EP, Monne M, Croce CM. Oral contraceptive‐induced expression of prostate‐specific antigen in female breast. J Biol Chem 1995;270 : 6615–6618. Medline [DOI] [PubMed] [Google Scholar]
- 6. Zarghami N, Grass L, Diamandis EP. Steroid hormone regulation of prostate‐specific antigen gene expression in breast cancer. Br J Cancer 1997;75:579–588. Medline [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Melegos DN, Diamandis EP. Diagnostic value of molecular forms of prostate‐specific antigen for female breast cancer. Clin Biochem 1996;29:193–200. Medline [DOI] [PubMed] [Google Scholar]
- 8. Giai M, Roagna R, Ponzone R, Katsaros D, Levesque MA, Diamandis EP. Prostate‐specific antigen in serum of women with breast cancer. Br J Cancer 1995;72:728–731. Medline [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Diamandis EP, Yu H. New biological functions of prostate‐specific antigen? J Clin Endocrinol Metab 1995;80:1515–1517. Medline [DOI] [PubMed] [Google Scholar]
- 10. Yu H, Diamandis EP. Prostate‐specific antigen in milk of lactating women. Clin Chem 1995;4:54–58. [PubMed] [Google Scholar]
- 11. Diamandis EP, Yu H, Lopez‐Otin C. Prostate‐specific antigen—a new constituent of breast cyst fluid. Breast Cancer Res Treat 1996;38:259–264. Medline [DOI] [PubMed] [Google Scholar]
- 12. Filella X, Molina R, Alcover J, Carretero P, Ballesta AM. Detection of nonprostatic PSA in serum and non‐serum samples from women. Int J Cancer 1996;68:424–427. Medline [DOI] [PubMed] [Google Scholar]
- 13. Filella X, Molina R, Alcover J, Casals E, Carmona F, Ballesta AM. Prostate‐specific antigen in non‐serum samples from women . Int J Biol Markers 1995;10:238–239. Medline [DOI] [PubMed] [Google Scholar]
- 14. Mannello F, Bocchiotti GD, Bianchi G, Marcheggiani F, Gazzanelli G. Quantification of prostate‐specific antigen immunoreactivity in human breast cyst fluids. Breast Cancer Res Treat 1996;38:247–252. Medline [DOI] [PubMed] [Google Scholar]
- 15. Filella X, Molina R, Alcover J, et al. Prostate‐specific antigen detection by ultrasensitive assay in samples from women. Prostate 1996;29:311–316. Medline [DOI] [PubMed] [Google Scholar]
- 16. Lai LC, Erbas H, Lennard TWJ, Peaston RT. Prostate‐specific antigen in breast cyst fluid: Possible role of prostate‐specific antigen in hormone‐dependent breast cancer. Int J Cancer 1996;66:743–746. Medline [DOI] [PubMed] [Google Scholar]
- 17. Yu H, Diamandis EP. Prostate‐specific antigen immunoreactivity in amniotic fluid. Clin Chem 1995;41:204–210. Medline [PubMed] [Google Scholar]
- 18. Bundred NJ, West RR, Dowd JO, Mansel RE, Hughes LE. Is there an increased risk of breast cancer in women who have had a breast cyst aspirated? Br J Cancer 1991;64:953–955. Medline [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Levitz M, Raju U, Boccardo F, Arcuri F, Castagnetta L. Steroid and cation correlations in human breast cyst fluid: preliminary findings. Cancer Detect Prev 1992;16:57–59. Medline [PubMed] [Google Scholar]
- 20. Borchert GH, Melegos DN, Tomlinson G, et al. Molecular forms of prostate‐specific antigen in the serum of women with benign and malignant breast diseases. Br J Cancer 1997;76:1087–1094. Medline [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Sauter ER, Daly M, Linahan K, et al. Prostate‐specific antigen levels in nipple aspirate fluid correlate with breast cancer risk. Cancer Epidemiol Biomarkers Prevent 1996;5:967–970.Medline [PubMed] [Google Scholar]
